Enhancing clinical and histopathological insights on COVID-19-associated mucormycosis (CAM).
作者信息
Mammen Divya Elizabeth, Johnson Rose
机构信息
Department of Otorhinolaryngology, Dr. D. Y. Patil Medical College, Hospital and Research Centre, Pimpri, Pune, Maharashtra, India.
出版信息
J Family Med Prim Care. 2025 Jun;14(6):2581-2582. doi: 10.4103/jfmpc.jfmpc_1348_24. Epub 2025 Jun 30.
Abstract
摘要
相似文献
1
Enhancing clinical and histopathological insights on COVID-19-associated mucormycosis (CAM).
J Family Med Prim Care. 2025 Jun;14(6):2581-2582. doi: 10.4103/jfmpc.jfmpc_1348_24. Epub 2025 Jun 30.
2
Comparative Mortality and Risk Analysis in Mucormycosis Cases: Pre-Pandemic Versus COVID-19 Association.
Indian J Otolaryngol Head Neck Surg. 2025 Aug;77(8):3040-3048. doi: 10.1007/s12070-025-05631-0. Epub 2025 Jun 3.
3
Clinical Features and Mortality of COVID-19-Associated Mucormycosis: A Systematic Review and Meta-Analysis.
Mycopathologia. 2022 Jun;187(2-3):271-289. doi: 10.1007/s11046-022-00627-8. Epub 2022 Mar 21.
4
Dependability and Prognostic Value of Biomarkers in COVID-19 Associated Rhino-Orbito- Cerebral Mucormycosis- A Long Term Ambispective Study.
Indian J Otolaryngol Head Neck Surg. 2024 Oct;76(5):4559-4568. doi: 10.1007/s12070-024-04921-3. Epub 2024 Jul 27.
5
COVID-19-associated mucormycosis: a systematic review and meta-analysis of 958 cases.
Clin Microbiol Infect. 2023 Jun;29(6):722-731. doi: 10.1016/j.cmi.2023.03.008. Epub 2023 Mar 13.
6
Metagenomic insights into fungal community composition of the nasopharyngeal region of COVID-19 associated mucormycosis patients from India.
J Med Virol. 2024 Apr;96(4):e29601. doi: 10.1002/jmv.29601.
7
Insights from Surgically treated Post Covid Acute Invasive Fungal Rhino-Orbital sinusitis in Chandrapur Study (SPAROS): A Population Based study of Coronavirus Associated Mucormycosis (CAM) characteristics in India.
IJID Reg. 2022 Dec;5:21-29. doi: 10.1016/j.ijregi.2022.08.005. Epub 2022 Aug 24.
8
Epidemiology and Pathophysiology of COVID-19-Associated Mucormycosis: India Versus the Rest of the World.
Mycopathologia. 2021 Dec;186(6):739-754. doi: 10.1007/s11046-021-00584-8. Epub 2021 Aug 19.
9
Multidisciplinary approach in diagnosis and treatment of COVID-19-associated mucormycosis: a description of current reports.
Egypt J Intern Med. 2022;34(1):58. doi: 10.1186/s43162-022-00143-7. Epub 2022 Jul 23.
10
Comparative Evaluation of COVID-19 Associated Mucormycosis (CAM) and Non-COVID-19-associated Mucormycosis (non-CAM).
J Coll Physicians Surg Pak. 2023 Feb;33(2):153-157. doi: 10.29271/jcpsp.2023.02.153.
本文引用的文献
1
Assessment of clinical and histopathological characteristics in COVID-19-associated mucormycosis (CAM) patients correlating with outcome: A hospital-based cross-sectional study.
J Family Med Prim Care. 2024 Aug;13(8):3115-3121. doi: 10.4103/jfmpc.jfmpc_18_24. Epub 2024 Jul 26.
2
When Uncontrolled Diabetes Mellitus and Severe COVID-19 Converge: The Perfect Storm for Mucormycosis.
J Fungi (Basel). 2021 Apr 15;7(4):298. doi: 10.3390/jof7040298.
3
COVID-19 endocrinopathy with hindsight from SARS.
Am J Physiol Endocrinol Metab. 2021 Jan 1;320(1):E139-E150. doi: 10.1152/ajpendo.00480.2020. Epub 2020 Nov 25.
4
A multicentre observational study on the epidemiology, risk factors, management and outcomes of mucormycosis in India.
Clin Microbiol Infect. 2020 Jul;26(7):944.e9-944.e15. doi: 10.1016/j.cmi.2019.11.021. Epub 2019 Dec 4.
5
Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes.
Acta Diabetol. 2010 Sep;47(3):193-9. doi: 10.1007/s00592-009-0109-4. Epub 2009 Mar 31.
Zotero 插件